Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults
Clinical trial NCT00385255 · COMPLETED
Trial details
- NCT number
- NCT00385255
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-23
- Primary completion
- 2007-02-28
- Enrollment
- 1726
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.